PUBLIC COMPANY
save$RYTMRHYTHM PHARMACEUTICALS, INC.
$RYTM112.36-3.80%Boston, MA, USupdated 2h ago
community read0 votes
pipeline
4
marketed
1
phase 3
0
catalysts ytd
4
approvals ytd
1
recalls ytd
0
Pipeline(4)
pipeline depth4 products
2Phase 21Marketed1Unknown
Upcoming
no upcoming catalysts on record
Recent(90d)
earnings (1)
Active trials
- phase3A Trial of Setmelanotide in Acquired Hypothalamic Obesity
- phase3Open-Label Extension Study of Setmelanotide
- phase2A Study of Setmelanotide in Patients With Prader-Willi Syndrome
- phase2A Study to Assess Efficacy and Safety of LB54640 in Patients With Hypothalamic Obesity
- phase3A Trial of Setmelanotide in Patients With Congenital Hypothalamic Obesity (Sub-study of NCT05774756)
- phase2A Long-Term Study of Bivamelagon in Participants With Hypothalamic Obesity (HO)
- phase3EMANATE: A Study of Setmelanotide in Patients With Specific Gene Variants in the MC4R Pathway
- phase2A Study of RM-718 in Healthy Subjects and Patients With MC4R Pathway Impairment
🐶 Hiring Signal
News
- Biopharma pushes beyond GLP-1s, weight loss at ObesityWeek 2026ObesityWeek 2026, which kicks off on Saturday, will spotlight presentations on the ascendant amylin pathway, as well as therapies looking to improve the quality of weight loss and patients’ persist…biospace · 7d ago
- Coveted metabolic gem Rhythm reportedly gets $10B offer from AstraZenecaAstraZeneca has apparently made a $10 billion bid to acquire Rhythm Pharmaceuticals, an offer William Blair suspects will not be the last for the hot ticket metabolic biotech.biospace · 15d ago
- AstraZeneca said to offer $10B to acquire Rhythm, analysts whisper of a bidding warAstraZeneca has made a roughly $10 billion offer to purchase rare obesity disease player Rhythm Pharmaceuticals, The Wall Street Journal reports. At least three teams of analysts suggest a bidding…fiercebiotech · 15d ago
- Gan & Lee's Phase 3 obesity successes; J&J touts multiple myeloma dataPlus news about Sanofi, PharmaMar, Jazz, Rhythm Pharmaceuticals, Spyre and Zymeworks 🇨🇳 Another obesity readout from China: Gan & Lee Pharmaceuticals, a China-based insulin specialist, announced…endpoints · 5mo ago
Data sources
last refreshed 12m ago
Found something off?
comments(0)
5-min edit window · permanent after that